Multiple sclerosis: Orally administered cladribine displays efficacy in multiple sclerosis trial

Nature Reviews Neurology

Volumn 6, Issue 4, 2010, Pages 182-

  Yates, Darran ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; PLACEBO; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; DISABILITY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RELAPSE; BRAIN; DRUG EFFECT; HUMAN; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADMINISTRATION, ORAL; BRAIN; CLADRIBINE; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77950823785     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.20     Document Type: Article

References (1)

1. Giovannoni, G. et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N. Engl. J. Med. 362, 416-426 (2010)